Abstract:Here, we present a gene regulation strategy enabling programmable control over eukaryotic translational initiation. By excising the natural poly-adenylation (poly-A) signal of target genes and replacing it with a synthetic control region harboring RNA-binding protein (RBP)-specific aptamers, cap-dependent translation is rendered exclusively dependent on synthetic translation initiation factors (STIFs) containing different RBPs engineered to conditionally associate with different eIF4F-binding proteins (eIFBPs). This modular design framework facilitates the engineering of various gene switches and intracellular sensors responding to many user-defined trigger signals of interest, demonstrating tightly controlled, rapid and reversible regulation of transgene expression in mammalian cells as well as compatibility with various clinically applicable delivery routes of in vivo gene therapy. Therapeutic efficacy was demonstrated in two animal models. To exemplify disease treatments that require on-demand drug secretion, we show that a custom-designed gene switch triggered by the FDA-approved drug grazoprevir can effectively control insulin expression and restore glucose homeostasis in diabetic mice. For diseases that require instantaneous sense-and-response treatment programs, we create highly specific sensors for various subcellularly (mis)localized protein markers (such as cancer-related fusion proteins) and show that translation-based protein sensors can be used either alone or in combination with other cell-state classification strategies to create therapeutic biocomputers driving self-sufficient elimination of tumor cells in mice. This design strategy demonstrates unprecedented flexibility for translational regulation and could form the basis for a novel class of programmable gene therapies in vivo.

Cryo-EM-guided engineering of T-box-tRNA modules with enhanced selectivity and sensitivity in translational regulation.

Structural and Dynamic Mechanisms for Coupled Folding and Trna Recognition of a Translational T-box Riboswitch.

Translational T-box riboswitches bind tRNA by modulating conformational flexibility

Capture and Release of tRNA by the T-Loop Receptor in the Function of the T-Box Riboswitch.

Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expression

Scaffold-enabled high-resolution cryo-EM structure determination of RNA

Engineering Translational Activators with CRISPR-Cas System.

RNA folding kinetics control riboswitch sensitivity in vivo

Alternative Mode of E-Site tRNA Binding in the Presence of a Downstream mRNA Stem Loop at the Entrance Channel

Cotranscriptional folding of a 5́ stem-loop in the Escherichia coli tbpA riboswitch at single-nucleotide resolution

Rational design of eukaryotic riboswitches that up-regulate IRES-mediated translation initiation with high switching efficiency through a kinetic trapping mechanism in vitro

Visualized and Precise Design of Artificial Small RNAs for Regulating T7 RNA Polymerase and Enhancing Recombinant Protein Folding in Escherichia Coli.

Recognition of Aminoacyl-Trna: a Common Molecular Mechanism Revealed by Cryo-Em

Synergetic regulation of translational reading-frame switch by ligand-responsive RNAs in mammalian cells

Structural Insights into Translation Regulation by the THF-II Riboswitch.

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

A transient intermediate RNA structure underlies the regulatory function of the E. coli thiB TPP translational riboswitch.

Precise tuning of bacterial translation initiation by non-equilibrium 5′-UTR unfolding observed in single mRNAs

Structural Characterization of the Cotranscriptional Folding of the Thiamin Pyrophosphate Sensing thiC Riboswitch in Escherichia coli

Cryo-EM structures of the human Elongator complex at work